Connecta Therapeutics
PrivateLast Round
Early Funding
Sep 10, 2026
Total Funding Raised
$16.83M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Connecta Therapeutics is a biotechnology company developing new treatments for central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Connecta Therapeutics Comparables
Compare Connecta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Confluence Pharmaceuticals | 84% | |
| Nospharma | 80% | |
| Spinogenix, Inc. | 79% |
Connecta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 10, 2026 | ||||
| Grant | Sep 9, 2025 | ||||
| Grant | Feb 12, 2024 | ||||
| Debt | Jun 6, 2023 | ||||
| Grant | Feb 3, 2022 | ||||
Seed | Jan 20, 2021 |
Key People
Founding team and executive leadership
Connecta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| CDTI Innvierte | Early Funding, Seed |
| Inveready | Early Funding, Seed |
| Prous Institute for Biomedical Research | Early Funding, Seed |
| Clave Capital | Early Funding |
| Empresa Nacional de Innovación | Debt |
| Center for Technological Development and Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2026
$3.6M raised, led by Clave Capital.
- Aug 20, 2026
Monthly visitors grew 112% MoM.
Recent news
Latest coverage and updates
- hiresSep 10, 2026
CONNECTA Therapeutics is to appoint Ignacio Prieto Fernández to its Board of Directors as Clave Capital’s representative in connection with the financing.
Connecta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Connecta Therapeutics's valuation, stock price, and market status.
Is Connecta Therapeutics a public or private company?
Connecta Therapeutics is a private company.
What is the current stock price of Connecta Therapeutics?
Connecta Therapeutics is a private company, so its shares have no public market price. Caplight tracks Connecta Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Connecta Therapeutics worth (valuation)?
Valuation information for Connecta Therapeutics is not publicly available.
Can I buy Connecta Therapeutics stock?
Connecta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Connecta Therapeutics's last funding round?
Connecta Therapeutics's most recent funding round was Early Funding on September 10, 2026.
Who are the main investors in Connecta Therapeutics?
Key investors in Connecta Therapeutics include Inveready, Clave Capital.
Will Connecta Therapeutics IPO soon?
No public IPO plans have been announced for Connecta Therapeutics.
How can I track Connecta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Connecta Therapeutics's shares on secondary markets.